IRWD - Ironwood Pharmaceuticals Inc. (IRWD) Q4 2023 Earnings Call Transcript
2024-02-15 12:17:02 ET
Ironwood Pharmaceuticals, Inc. (IRWD)
Q4 2023 Earnings Call Transcript
February 15, 2024 08:30 AM ET
Company Participants
Matt Roache - Director of Investor Relations
Tom McCourt - Chief Executive Officer
Mike Shetzline - Chief Medical Officer
Sravan Emany - Chief Financial Officer
Conference Call Participants
Amy Li - Jefferies
Mohit Bansal - Wells Fargo
Chase Knickerbocker - Craig-Hallum
Jason Butler - JMP Securities
Tim Chiang - Capital One
Presentation
Operator
Good day, and welcome to the Ironwood Pharmaceuticals Fourth Quarter and Full Year 2023 Investor Update Call. [Operator Instructions]. And finally, I would like to advise all participants that this call is being recorded. Thank you.
I'd now like to welcome Matt Roache, Director of Investor Relations to begin the conference. Matt, over to you.
Matt Roache
Thank you, Gavin. Good morning, and thanks for joining us for our fourth quarter and full year 2023 investor update. Our press release issued this morning can be found on our website. Today's call and accompanying slides include forward-looking statements. Such statements involve risks and uncertainties that may cause actual results to differ materially. A discussion of these statements and risk factors is available on the current safe harbor statement slide as well as under the heading Risk Factors in our annual report on Form 10-K for the year ended December 31, 2022, and our quarterly report on Form 10-Q for the quarters ended June 30, 2023, at September 30, 2023, and in our subsequent SEC filings.
All forward-looking statements speak as of the date of this presentation, we undertake no obligation to update such statements. Also included our non-GAAP financial measures, which should be considered only as a supplement to and not a substitute for or superior to GAAP measures. To the extent applicable, please refer to the tables at the end of our press release for reconciliations of these measures to the most directly comparable GAAP measures.
During today's call, Tom McCourt, our Chief Executive Officer, will begin with a brief overview. Mike Shetzline, our Chief Medical Officer, will discuss our pipeline and Sravan Emany, our Chief Financial Officer, to provide a commercial update and review our financial results and guidance. Today's webcast includes slides. So, for those of you dialing in, please go to the Events section of our website to access the accompanying slide separately. ...
Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2023 Earnings Call Transcript